23 May 2013
Keywords: isis, receives, milestone, payment, eli, lilly, california
Article | 13 February 2006
California, USA-based Isis Pharmaceuticals says that US drug major Eli Lilly has begun clinical trials of LY2275796, which it licenses ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 February 2006
20 February 2006
© 2013 thepharmaletter.com